Provided by Tiger Trade Technology Pte. Ltd.

LAVA Therapeutics N.V.

1.74
0.0000
Volume:- -
Turnover:- -
Market Cap:45.77M
PE:-2.02
High:1.74
Open:1.74
Low:1.74
Close:1.74
52wk High:2.00
52wk Low:0.8502
Shares:26.31M
Float Shares:10.22M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8620
EPS(LYR):-0.9359
ROE:-101.51%
ROA:-19.92%
PB:3.61
PE(LYR):-1.86

Loading ...

Nov 21, 2025

Delisting

Form 25-NSE/A - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: [Amend]
Nov 21, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Nov 21, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Nov 21, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 17, 2025

Major Issues Report

Form 8-K - Current report
Oct 02, 2025

Major Issues Report

Form 8-K - Current report
Sep 30, 2025

Major Issues Report

Form 8-K - Current report
Aug 14, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
May 23, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Feb 28, 2025

Major Issues Report

Form 8-K - Current report